Annual Interdiciplinary Breast Cancer Conference
Ambry Genetics is a pround sponsor of the 2024 NCBC Annual Meeting and supporter of the NCBC organization. We invite you to visit us at booth 501+505 to learn more about Ambry's CARE program, our risk assessment tool that makes is easy to identify high-risk patients who qualify for hereditary cancer testing. Ambry offers paired DNA and RNA testing that helps identify more cases of hereditary cancer and fewer variants of uncertain significance (VUS).
Click HERE to learn more about Ambry's hereditary cancer testing or any of our other test offerings.
Poster # tbd
Friday, March 15, 2024 12:00 - 12:00pm Abstract Poster
Heather Fecteau, Haley Keller, Meagan Farmer, Carrie Horton, Shannon Kieran. Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants.